Board of Directors

The Board of Directors is responsible for the group's system of corporate governance and is ultimately accountable for the group's activities, strategy, risk management and financial performance.

The Chief Executive Officer is responsible for the management of the business and is assisted by the Corporate Executive Team.

Membership of board committees
Board memberAudit and riskCorporate administration & transactionsCorporate responsibilityNominationsRemunerationScience committee
Sir Philip Hampton   Member   Chairman    
Sir Andrew Witty*   Member        
Emma Walmsley   Member        
Simon Dingemans   Member        
Dr Moncef Slaoui**   Member        
Professor Sir Roy Anderson   Member Member Member   Member
Manvinder Singh (Vindi) Banga Member  Member    Member  Member  
Dr Patrick Vallance   Member        
Dr Vivienne Cox   Member Member    Member  
Lynn Elsenhans Member Member Chair Member    
Dr Jesse Goodman   Member Member     Chairman
Judy Lewent Chair Member   Member Member Member
Urs Rohner   Member   Member Chairman  

* Sir Andrew Witty will step down from the Board when he retires on 31 March 2017
** Dr Moncef Slaoui will step down from the Board on 31 March 2017. He will then serve as an adviser to GSK and to the Board until he retires from the company on 30 June 2017